Integrated platform to validate vesicular trafficking-associated processes in neurodegenerative diseases. KU Leuven
The incidence of neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD), is increasing in our aging population. These chronic illnesses have a significant impact on the quality of life of patients and their carers, but cause an increasing economic burden on our society as well. Therapeutic strategies that interfere with the underlying pathogenesis of AD and PD and stop or slow down neurodegeneration have yet ...